Menu
Back to User profile » Dr Ted Cole
Papers published by Dr Ted Cole:
Parkinson’s Disease-Associated Melanin Steal [Retraction]
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2021, 17:733-734
Published Date: 3 March 2021
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:43-44
Published Date: 3 March 2021
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:41-42
Published Date: 3 March 2021
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2021, 13:39-40
Published Date: 3 March 2021
Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2020, 16:3125-3126
Published Date: 16 December 2020
Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2020, 12:271-272
Published Date: 16 December 2020
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2020, 12:43-44
Published Date: 23 April 2020
Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2020, 16:1061-1062
Published Date: 23 April 2020
Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2020, 16:1063-1064
Published Date: 23 April 2020
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2020, 12:45-46
Published Date: 23 April 2020
Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2020, 12:59-60
Published Date: 23 April 2020
Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2020, 12:47-48
Published Date: 23 April 2020
Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2016, 12:1587-1588
Published Date: 28 June 2016
Parkinson’s disease managing reversible neurodegeneration
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2016, 12:763-775
Published Date: 5 April 2016
Parkinson’s disease-associated melanin steal
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2014, 10:2331-2337
Published Date: 10 December 2014
Parkinson's disease: carbidopa, nausea, and dyskinesia
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:189-194
Published Date: 14 November 2014
The Parkinson's disease death rate: carbidopa and vitamin B6
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:161-169
Published Date: 21 October 2014
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2014, 6:107-110
Published Date: 22 July 2014
Management of L-dopa overdose in the competitive inhibition state
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2014, 6:93-99
Published Date: 22 July 2014